P871Coronary artery aneurysms: clinical features, management and long-term outcomes, insights from the international coronary artery aneurysm registry (CAAR)

Abstract

Background Coronary Aneurysms are a focal dilatation of an artery segment of >1.5-fold the normal size of adjacent segments. Some limited series suggested an incidence of 0.3–12%. However, coronary aneurysms are not mentioned in practice guidelines and several questions remain unanswered. Purpose To investigate its clinical profile, prognostic predictors, and long term outcomes. Methods The coronary artery aneurysm registry (CAAR, NCT02563626) is a collaborative effort involving 32 hospitals across 9 countries (Canada, Cuba, Czech Republic, Germany, Italy, Netherlands, Spain, USA and Uruguay). When eligibility was uncertain, cases were reviewed by a core lab. Results We reviewed 436,467 consecutive angiographies between 2004–2016. 1,565 patients were ambispectively included. Global incidence was 0.35%. Most were male (78.5%) with a mean age of 65 years. Cardiovascular risk factors were frequent. An aortopathy history was present in 8.7% but a Kawasaki antecedent was unfrequent (0.3%). The main indication for cath was an ACS in 966 cases. Most aneurysms were saccular and 82 giant. The number of aneurisms was low, mainly with 1–2 (95.8%) and only 3 patients with ≥6, proportionally with more coronary stenosis. The most affected artery was the LAD. Aortopathy was related with higher number of aneurysms. Most received any revascularization, commonly percutaneous (PCI). During a follow-up of 37.2 months, 485 suffered a MACE, (death/heart failure/unstable angina/reinfarction) and 240 died. Age, race, diabetes, renal failure, peripheral disease, acute cath, coronary stenosis, LVEF and anticoagulation remained as predictors of death/MACE after multivariate adjustments, without no major differences comparing CABG vs PCI. No restenosis was found in aneurysm with DES but those with BMS suffered 4 (p=0.002). MACE and death were more frequent in patients who received BMS. Figure 1 Conclusions Coronary aneurysmal disease is not uncommon. It is associated with severe coronary stenosis and a high cardiovascular risk burden, pointing out an aggressive atherosclerotic status. Antiplatelet therapy is a reasonable option and interventional procedures safe and effective, compared with surgery. Drug eluting stents should be preferred as the default strategy. Acknowledgement/Funding None

Right Coronary-Left Ventricular Fistula and Its Course: A Case Report

“…A dilated coronary artery carries a higher risk of thrombosis when the fistula is manipulated with closure through a surgical or percutaneous catheter, thus there is a certain necessity for postoperative anticoagulation therapy in such patients. However, there is no standard protocol for anticoagulation in these patients, and anticoagulation with conventional warfarin or dual agent use of aspirin or clopidogrel has been reported [Nunez-Gil 2018;Nunez-Gil 2019].…”

Relation between Coronary Artery Ectasia Characteristics and Development of Acute Coronary Syndrome

“…Previous research found that risk variables for CAE include younger age, male gender, obesity, smoking, hypertension, hyperlipidemia, peripheral vascular disease, and higher levels of inflammatory markers (24) . However, the majority of the data come from limited investigations or case studies.…”

Olgular Eşliğinde Kardiyoloji II

“…Yapılan bazı çalışmalarda, KAA ile KAH arasında bir mortalite farkı görülmemiştir (3,9). Yaklaşık 1500 hastayı içeren Koroner Arter Anevrizması Kaydı (CAAR) çalışmasında ise mortalite ve majör advers kardiyak olay izlenmiştir (39).…”